Archive · 2 Jun 2025
Mixed Q4 Earnings: Pharma & Cement Sector Performance Review
Several Indian companies released their financial results for the last quarter.
IPCA Labs, a drug maker, made more profit and earned more money compared to last year.
HeidelbergCement India, a cement maker, made a bit less profit but still earned more money.
Granules India, another drug maker, also saw an increase in profit.
Natco Pharma's profit and revenue also increased.
Balaji Amines, reported a fall in revenue and profit.
Overall, it was a mixed bag of results for these companies, with some doing well and others facing challenges in the market.
IPCA Labs' net profit rose 14% YoY, with revenue up 11% in Q4.
HeidelbergCement India saw a 3% dip in net profit but a 2.7% increase in revenue for Q4.
Granules India reported an 18% increase in net profit, despite a slight 1.8% rise in revenue.
Natco Pharma's net profit increased by 5%, and revenue grew by 16% in Q4.
Balaji Amines reported a 15% decrease in consolidated revenue and 44% drop in profit in Q4.
- Who
- IPCA Labs, HeidelbergCement India, Granules India, Natco Pharma, and Balaji Amines.
- What
- Companies reported their financial results.
- When
- The last quarter ending March 31, 2025.
- Where
- India
- Why
- To provide updates on financial performance.
- IPCA Labs Q4 Net Profit (YoY)
- ₹68 crore, up 14%
- IPCA Labs Q4 Revenue (YoY)
- ₹2,247 crore, up 11%
- HeidelbergCement India Q4 Net Profit (YoY)
- ₹50 crore, down 3%
- HeidelbergCement India Q4 Revenue (YoY)
- ₹612.4 crore, up 2.7%
- Granules India Q4 Net Profit (YoY)
- ₹152 crore, up 18%
- Granules India Q4 Revenue (YoY)
- ₹1,197.5 crore, up 1.8%
- Natco Pharma Q4 Net Profit (YoY)
- ₹406 crore, up 5%
- Natco Pharma Q4 Revenue (YoY)
- ₹1,287.3 crore, up 16%
- Balaji Amines Q4 Revenue (YoY)
- ₹353 crore, down 15%
- Balaji Amines Q4 PAT (YoY)
- ₹40.4 crore, down 44%
Sources
Natco Pharma Q4 Results: Profit rises 5%, revenue up 16% YoY; warns of FY26 headwinds
Balaji Amines share fall up to 7% after weakness persists on revenue, margins in Q4
IPCA Labs Q4 Results: Revenue and margin grow from last year; dividend announced
Granules India Q4 Results: 50% fall in European sales offset by North America, India